RxDoctor Payments Data

Ashley Mazei

Family · Westminster, MDNPI 1568711901

Payments from drug & device makers

$3,377in general payments, 2019–2025

Across 119 payments — averaging $28.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Biodelivery Sciences International, Inc.$749
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$303
  • Amgen$171
  • AbbVie$136
  • Collegium Pharmaceutical, Inc.$122
  • plus $696 from 14 others

What the payments were for

  • Speaking & faculty fees$60018%
  • Travel & lodging$71521%
  • Food & beverage$2,03860%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,377 in reported general payments places this provider in the 90th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$6,287
Medicare patients
17
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl356$53,262
Fentanyl19$3,522
Oxycodone Hcl93$1,802
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39$1,047
Gabapentin58$1,029
Morphine Sulfate ErMorphine Sulfate27$905
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$673
Tramadol Hcl34$500
Pregabalin21$486
Tizanidine Hcl23$232
Mirtazapine15$116
Cyclobenzaprine Hcl14$74
Hydroxyzine Hcl12$64

Paid to pharmacies, not to this prescriber.

Other family in Westminster

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →